Cargando…
In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model
AZ465 is a novel selective transient receptor potential cation channel, member A1 (TRPA1) antagonist identified during a focused drug discovery effort. In vitro, AZ465 fully inhibits activation by zinc, O-chlorobenzylidene malononitrile (CS), or cinnamaldehyde of the human TRPA1 channel heterologous...
Autores principales: | Nyman, Eva, Franzén, Bo, Nolting, Andreas, Klement, Göran, Liu, Gang, Nilsson, Maria, Rosén, Annika, Björk, Charlotta, Weigelt, Dirk, Wollberg, Patrik, Karila, Paul, Raboisson, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565573/ https://www.ncbi.nlm.nih.gov/pubmed/23403691 http://dx.doi.org/10.2147/JPR.S37567 |
Ejemplares similares
-
TRPA1 Antagonists for Pain Relief
por: Koivisto, Ari, et al.
Publicado: (2018) -
Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists
por: Klionsky, Lana, et al.
Publicado: (2007) -
TRPM8 and TRPA1 do not contribute to dental pulp sensitivity to cold
por: Michot, Benoit, et al.
Publicado: (2018) -
A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain
por: Nativi, Cristina, et al.
Publicado: (2013) -
Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors
por: Kerstein, Patrick C, et al.
Publicado: (2009)